Compare BIO & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | HBM |
|---|---|---|
| Founded | 1952 | 1927 |
| Country | United States | Canada |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Metal Mining |
| Sector | Industrials | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.2B |
| IPO Year | N/A | 2005 |
| Metric | BIO | HBM |
|---|---|---|
| Price | $264.92 | $18.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $358.50 | $25.00 |
| AVG Volume (30 Days) | 235.7K | ★ 5.4M |
| Earning Date | 04-30-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 0.08% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | $29.94 |
| Revenue Next Year | $3.05 | $13.16 |
| P/E Ratio | ★ $9.72 | $21.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $5.95 |
| 52 Week High | $343.12 | $28.74 |
| Indicator | BIO | HBM |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 27.18 |
| Support Level | $239.33 | $14.25 |
| Resistance Level | $289.61 | $28.64 |
| Average True Range (ATR) | 7.46 | 1.12 |
| MACD | 0.44 | -0.66 |
| Stochastic Oscillator | 19.99 | 6.38 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Hudbay Minerals Inc is a copper-focused critical minerals company with three long-life operations and a pipeline of copper growth projects in Canada, Peru, and the United States. Its operating portfolio includes the Constancia mine in Cusco (Peru), the Snow Lake operations in Manitoba (Canada), and the Copper Mountain mine in British Columbia (Canada). Copper is the primary metal produced by the company, which is complemented by gold, zinc, silver, and molybdenum production. Hudbay's growth pipeline includes the Copper World project and the Mason project in the USA, and the Llaguen project in Peru. The company's reportable segments are: Peru, which generates the maximum revenue, Manitoba, British Columbia, and Arizona. Geographically, it generates maximum revenue from China and Canada.